176 related articles for article (PubMed ID: 38417449)
1. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
[TBL] [Abstract][Full Text] [Related]
2. Identification of salivary metabolomic biomarkers for oral cancer screening.
Ishikawa S; Sugimoto M; Kitabatake K; Sugano A; Nakamura M; Kaneko M; Ota S; Hiwatari K; Enomoto A; Soga T; Tomita M; Iino M
Sci Rep; 2016 Aug; 6():31520. PubMed ID: 27539254
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma.
Ohshima M; Sugahara K; Kasahara K; Katakura A
Oncol Rep; 2017 May; 37(5):2727-2734. PubMed ID: 28393236
[TBL] [Abstract][Full Text] [Related]
4. Salivary metabolomics with alternative decision tree-based machine learning methods for breast cancer discrimination.
Murata T; Yanagisawa T; Kurihara T; Kaneko M; Ota S; Enomoto A; Tomita M; Sugimoto M; Sunamura M; Hayashida T; Kitagawa Y; Jinno H
Breast Cancer Res Treat; 2019 Oct; 177(3):591-601. PubMed ID: 31286302
[TBL] [Abstract][Full Text] [Related]
5. Salivary metabolomics with machine learning for colorectal cancer detection.
Kuwabara H; Katsumata K; Iwabuchi A; Udo R; Tago T; Kasahara K; Mazaki J; Enomoto M; Ishizaki T; Soya R; Kaneko M; Ota S; Enomoto A; Soga T; Tomita M; Sunamura M; Tsuchida A; Sugimoto M; Nagakawa Y
Cancer Sci; 2022 Sep; 113(9):3234-3243. PubMed ID: 35754317
[TBL] [Abstract][Full Text] [Related]
6. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
7. Effect of timing of collection of salivary metabolomic biomarkers on oral cancer detection.
Ishikawa S; Sugimoto M; Kitabatake K; Tu M; Sugano A; Yamamori I; Iba A; Yusa K; Kaneko M; Ota S; Hiwatari K; Enomoto A; Masaru T; Iino M
Amino Acids; 2017 Apr; 49(4):761-770. PubMed ID: 28101653
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study.
Takamori S; Ishikawa S; Suzuki J; Oizumi H; Uchida T; Ueda S; Edamatsu K; Iino M; Sugimoto M
Thorac Cancer; 2022 Feb; 13(3):460-465. PubMed ID: 34918488
[TBL] [Abstract][Full Text] [Related]
9. Development of isotope labeling LC-MS for human salivary metabolomics and application to profiling metabolome changes associated with mild cognitive impairment.
Zheng J; Dixon RA; Li L
Anal Chem; 2012 Dec; 84(24):10802-11. PubMed ID: 23150892
[TBL] [Abstract][Full Text] [Related]
10. Metabolome of canine and human saliva: a non-targeted metabolomics study.
Turunen S; Puurunen J; Auriola S; Kullaa AM; Kärkkäinen O; Lohi H; Hanhineva K
Metabolomics; 2020 Aug; 16(9):90. PubMed ID: 32840693
[TBL] [Abstract][Full Text] [Related]
11. Urinary charged metabolite profiling of colorectal cancer using capillary electrophoresis-mass spectrometry.
Udo R; Katsumata K; Kuwabara H; Enomoto M; Ishizaki T; Sunamura M; Nagakawa Y; Soya R; Sugimoto M; Tsuchida A
Sci Rep; 2020 Dec; 10(1):21057. PubMed ID: 33273632
[TBL] [Abstract][Full Text] [Related]
12. Salivary metabolomics profile of patients with recurrent aphthous ulcer as revealed by liquid chromatography-tandem mass spectrometry.
Li Y; Wang D; Zeng C; Liu Y; Huang G; Mei Z
J Int Med Res; 2018 Mar; 46(3):1052-1062. PubMed ID: 29332424
[TBL] [Abstract][Full Text] [Related]
13. The early diagnosis and monitoring of squamous cell carcinoma via saliva metabolomics.
Wang Q; Gao P; Wang X; Duan Y
Sci Rep; 2014 Oct; 4():6802. PubMed ID: 25354816
[TBL] [Abstract][Full Text] [Related]
14. Salivary metabolites are promising noninvasive biomarkers of drug-induced liver injury.
Yu SM; Zheng HC; Wang SC; Rong WY; Li P; Jing J; He TT; Li JH; Ding X; Wang RL
World J Gastroenterol; 2024 May; 30(18):2454-2466. PubMed ID: 38764769
[TBL] [Abstract][Full Text] [Related]
15. High-resolution metabolomic biomarkers for lung cancer diagnosis and prognosis.
Qi SA; Wu Q; Chen Z; Zhang W; Zhou Y; Mao K; Li J; Li Y; Chen J; Huang Y; Huang Y
Sci Rep; 2021 Jun; 11(1):11805. PubMed ID: 34083687
[TBL] [Abstract][Full Text] [Related]
16. Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification.
Wang X; Liu L; Du Q; Sun Z; Yue E; Xue P; Zhao H
Recent Pat Anticancer Drug Discov; 2021; 16(3):417-425. PubMed ID: 33655848
[TBL] [Abstract][Full Text] [Related]
17. Untargeted saliva metabonomics study of breast cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Zhong L; Cheng F; Lu X; Duan Y; Wang X
Talanta; 2016 Sep; 158():351-360. PubMed ID: 27343615
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
19. Salivary metabolite signatures of oral cancer and leukoplakia.
Wei J; Xie G; Zhou Z; Shi P; Qiu Y; Zheng X; Chen T; Su M; Zhao A; Jia W
Int J Cancer; 2011 Nov; 129(9):2207-17. PubMed ID: 21190195
[TBL] [Abstract][Full Text] [Related]
20. Identification of salivary metabolites for oral squamous cell carcinoma and oral epithelial dysplasia screening from persistent suspicious oral mucosal lesions.
Ishikawa S; Wong DTW; Sugimoto M; Gleber-Netto FO; Li F; Tu M; Zhang Y; Akin D; Iino M
Clin Oral Investig; 2019 Sep; 23(9):3557-3563. PubMed ID: 30539290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
